Skip to content
healthcare.dev

FLUDEOXYGLUCOSE F-18

NDC 78714-001, FLUDEOXYGLUCOSE F-18, injection, from Barbara Ann Karmanos Cancer Hospital.

Product NDC
78714-001
Status
Listed
Labeler
Barbara Ann Karmanos Cancer Hospital
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204385
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/78714-001 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FLUDEOXYGLUCOSE F-18300 mCi/mL

Pharmacologic classes

Radioactive Diagnostic Agent [EPC]; Radiopharmaceutical Activity [MoA]

Package NDCNDC-11Package
78714-001-307871400013030 mL in 1 VIAL, GLASS (78714-001-30)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e3791140-2e52-48c5-9849-536d5e4275e5

Use it

Look up 78714-001 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/78714-001 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 78714-001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.